Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy

Clinical trial NCT03407040 · TERMINATED

Trial details

NCT number: NCT03407040
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Study type: OBSERVATIONAL

Gastrointestinal Cancers Breast Cancer Pancreatic Cancer Melanoma Lung Cancer

Start date: 2018-01-30
Primary completion: 2019-08-27
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.